Moderna's planned COVID-19 vaccine price hike criticized by White House
Drew Angerer/Getty Images News


Moderna's (NASDAQ:MRNA) plan to increase the price of its COVID-19 shot to as much as $130 per dose is "hard to justify," White House Press Secretary Karin Jean-Pierre said at a briefing.
Jean-Pierre noted that President Biden shares concerns expressed by Sen. Bernie Sanders (I-Vt.) over the potential price hike.

On Tuesday, Sanders sent a letter to CEO Stephane Bancel calling the proposed increase "unacceptable corporate greed."
In an interview with The Wall Street Journal on Monday, Bancel said he was considering a range of $110-$130 per dose when the vaccines hit the commercial market. That's the same range Pfizer (PFE) has proposed for its vaccine.
COVID vaccines are currently available for free for everyone as part of federal government purchases, but that will cease once the public health emergency over the disease ends. The emergency was just extended another 90 days on Wednesday, though there are indications this was the last extension.